Reportlinker Adds mHealth and Home Monitoring - 3rd Edition

NEW YORK, Dec. 29, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

mHealth and Home Monitoring – 3rd Edition

http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-3rd-Edition.html

Summary

Executive summary

eHealth is a term for healthcare practice supported by electronic processes and communication. More recently, mHealth has begun to appear as a term for eHealth using mobile phones or cellular networks. mHealth is a very broad term that principally involves every kind of mobile health related communication, application or data service. This report covers home health monitoring involving patient self-testing using medical devices and remote transmission of the medical data to healthcare providers for disease management. Some of the most common conditions being monitored today are chronic diseases including cardiac arrhythmia, hypertension, ischemic diseases, sleep apnea, diabetes, hyperlipidemia, asthma and chronic obstructive pulmonary disease (COPD). These diseases are often but not always related to lifestyle. These conditions cause substantial costs and reduce both life expectancy and quality of life. The market for home health monitoring of welfare diseases was worth approximately € 7.6 billion in 2010 and is growing about 9 percent annually. The diabetes monitoring segment is by far the largest segment, worth about € 6.3 billion. The market includes revenues from monitoring equipment, disposable materials and services. Wireless technologies have only just begun to penetrate the market. Berg Insight estimates that more than 200 million people in the EU and the US suffer from one or several diseases where home monitoring can become a treatment option. Additionally, there are those monitoring their personal health without a strict medical need and those monitoring their medication intake. At the end of 2010, an estimated 1 million patients used a home monitoring service based on equipment with integrated connectivity. The figure does not include patients that use monitoring devices connected to a PC or mobile phone; it only includes systems that rely on monitors with integrated connectivity or systems that use monitoring hubs with integrated cellular or fixed-line modems.

Several companies have developed integrated solutions for monitoring of multiple chronic diseases and other conditions. Examples include major technology and electronics companies including Bosch, Honeywell and Philips, or small specialist telehealth companies such as Cardiocom, iMetrikus, MedApps and SHL Telemedicine. Many medical device companies are also active in sales of devices and services focusing on specific vital signs or medical conditions. mHealth has also attracted the interest of many of the leading players in the telecom and IT industries. Business opportunities exist in offering connectivity and data centre infrastructure and services for service providers and device manufacturers that provide home medical monitoring services directly to patients or caregivers. Moreover, a growing number of application developers have released health and wellness apps for smartphones. Common app types include BMI and calorie calculators, diet guides, exercise guides and sport tracking apps. There are also many medical reference and chronic disease management apps available. In the future, smartphones are likely to be the primary monitoring device for many patients. More and more vital sign meters can be connected to handsets or PCs using for instance Bluetooth. The adoption of out-of-hospital wireless monitoring in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. However, there are also challenges such as the financing of wireless solutions by what is at large an underfunded healthcare sector. In order to receive reimbursement, suppliers of medical products not only have to prove their worth in a clinical perspective, but also in an economical perspective. With rising healthcare costs, there is an increasing focus on early diagnosis and home treatment – potentially enabled by new technology. Several potential catalysts could speed up the adoption of cellular communication for healthcare monitoring purposes. These include increasing monitoring during clinical trials, insurance company requirements and growing popularity for non prescribed medical monitoring.

Table of Contents

Table of Contents i

List of Figures.vii

Executive summary 1

1 The challenge from welfare diseases .3

1.1 Introduction 3

1.1.1 The ageing world population ..3

1.1.2 Metabolic syndrome and lifestyle related diseases .4

1.2 Common chronic diseases 5

1.2.1 Cardiac arrhythmia 6

1.2.2 Hypertension 7

1.2.3 Ischemic diseases. 7

1.2.4 Sleep apnea .8

1.2.5 Chronic respiratory diseases ..9

1.2.6 Diabetes ..12

1.2.7 Hyperlipidemia .13

1.3 Healthcare providers and reimbursement systems ..14

1.3.1 Healthcare in Asia and Australia .16

1.3.2 Healthcare in Europe 17

1.3.3 Healthcare in North America .20

2 mHealth and telecom industry initiatives 23

2.1 Telecom operators..24

2.1.1 AT&T announces ForHealth practice area and service portfolio 25

2.1.2 Orange Group aims for leadership in eHealth services..26

2.1.3 Qualcomm remains highly active in mHealth after cancelling MVNO plans 27

2.1.4 SaskTel and Alcatel-Lucent cooperates on remote patient monitoring..28

2.1.5 TELUS hosts and operates Microsoft's HealthVault platform in Canada ..28

2.1.6 Verizon Communications and Verizon Wireless .29

2.1.7 Vodafone establishes Health Solutions business unit .29

2.2 Mobile handsets ..31

2.2.1 Smartphone vendors and operating systems..31

2.2.2 Application stores provide a new channel to the market for developers 33

2.2.3 Medical applications..34

2.3 Personal health record initiatives.35

2.3.1 Google Health ..35

2.3.2 Microsoft HealthVault 36

2.3.3 Dossia personal health platform .37

2.4 Industry associations.38

2.4.1 Continua Health Alliance.38

2.4.2 The Bluetooth SIG Medical Working Group..39

2.4.3 American Telemedicine Association .40

2.4.4 CTIA40

2.4.5 GSMA 40

2.4.6 mHealth Alliance .41

2.4.7 West Wireless Health Institute..41

2.4.8 Wireless-Life Sciences Alliance 41

3 Home healthcare monitoring 43

3.1 Trends in health monitoring 44

3.1.1 Going digital, going wireless.45

3.1.2 Distance disease management 47

3.1.3 Outsourcing of health monitoring ..48

3.2 Medical monitoring devices 50

3.2.1 Cardiac monitoring.50

3.2.2 Blood pressure monitoring.53

3.2.3 Blood coagulation monitoring..54

3.2.4 Blood oxygen level monitoring 54

3.2.5 Glucose monitoring 55

3.2.6 Lipid monitoring ..57

3.2.7 Sleep monitoring .58

3.2.8 Breath monitoring 58

3.3 Regulatory environment ..59

3.3.1 Regulatory environment in Europe 59

3.3.2 Regulatory environment in the US .60

3.3.3 Regulatory environment on other major markets ..61

3.3.4 International standardisation.62

3.4 Wireless M2M technology ..63

3.4.1 Chipsets, modules and terminals 64

3.4.2 M2M network services..65

4 Physiological monitoring solution providers 67

4.1 Cardiac monitoring .69

4.1.1 CardioNet 69

4.1.2 LifeWatch.70

4.1.3 Aerotel Medical Systems.72

4.1.4 Biotronik ..72

4.1.5 Boston Scientific..73

4.1.6 Corventis .73

4.1.7 Curvus ..73

4.1.8 eCardio Diagnostics..74

4.1.9 Kiwok.74

4.1.10 Medtronic 74

4.1.11 SHL Telemedicine ..75

4.1.12 Sorin Group 76

4.1.13 St Jude Medical 76

4.2 Blood pressure monitoring.77

4.2.1 Omron Healthcare..77

4.2.2 A&D Medical..78

4.2.3 Microlife 78

4.2.4 IEM .79

4.2.5 Medisana. 79

4.2.6 Rossmax..79

4.3 Coagulation monitoring 80

4.3.1 Alere ..80

4.3.2 CoaguSense..81

4.3.3 Thoratec ..81

4.4 Sleep monitoring .81

4.4.1 ResMed 81

4.4.2 CareFusion.82

4.4.3 Braebon 82

4.4.4 Cadwell.83

4.4.5 CleveMed 83

4.4.6 Embla 83

4.4.7 Grass Technologies ..83

4.5 Blood oxygen monitoring 84

4.5.1 Covidien ..84

4.5.2 Masimo.85

4.5.3 Nonin Medical ..85

4.5.4 Opto Circuits .85

4.6 Air flow monitoring..86

4.6.1 Smiths Medical .86

4.6.2 Clement Clarke International.86

4.6.3 Medical Electronic Construction .87

4.6.4 Medical International Research 87

4.6.5 Midmark 87

4.6.6 Ndd Medizintechnik 87

4.6.7 nSpire Health.88

4.6.8 SDI Diagnostics 88

4.6.9 Sibelmed .88

4.6.10 Welch Allyn.88

4.7 Glucose level monitoring.89

4.7.1 Abbott Laboratories 90

4.7.2 Bayer Healthcare.90

4.7.3 Johnson & Johnson ..91

4.7.4 Roche 92

4.7.5 DexCom 93

4.8 Lipid monitoring 93

4.8.1 CardioChek 93

4.8.2 Apex Biotechnology ..94

4.8.3 Biomedix..94

5 Medication and integrated monitoring solution providers.95

5.1 Integrated telehealth solution providers..95

5.1.1 GE and Intel forms telehealth joint venture 96

5.1.2 Honeywell HomMed..97

5.1.3 Philips Healthcare ..98

5.1.4 Bosch Healthcare 98

5.1.5 BodyTel 99

5.1.6 Cardiocom 100

5.1.7 iMetrikus 100

5.1.8 MedApps ..100

5.1.9 Medic4All..101

5.1.10 OBS Medical ..101

5.1.11 Tunstall Group 102

5.1.12 Vitaphone .102

5.2 Medication compliance monitoring .103

5.2.1 Aardex Group.103

5.2.2 Bang & Olufsen Medicom 103

5.2.3 Cypak .104

5.2.4 Information Mediary Corporation .104

5.2.5 M-PLIFY .104

5.2.6 Proteus Biomedical .105

5.2.7 SIMpill.105

5.2.8 Vitality .106

5.2.9 Vocel 106

6 Market analysis and forecasts ..107

6.1 Market analysis ..107

6.2 Market drivers and barriers..111

6.2.1 An ageing population.111

6.2.2 Increasing welfare disease prevalence .112

6.2.3 Focus on disease prevention.112

6.2.4 Substitutes to medical monitoring ..113

6.3 Potential market catalysts.114

6.3.1 Increased monitoring during clinical trials ..114

6.3.2 Insurance companies demanding monitoring ..115

6.3.3 Non-prescribed monitoring and healthcare consumerism.115

6.4 Market forecast ..116

6.5 Recommendations for mobile industry players.117

Glossary 119

List of Figures

Figure 1.1: Population by age group (EU, North America and Japan 2010-2030) ..4

Figure 1.2: Direct and indirect costs of chronic welfare diseases in the US and EU..6

Figure 1.3: Number of people suffering from chronic welfare diseases (EU/US 2008) .9

Figure 1.4: Percentage of population diagnosed with chronic welfare diseases 11

Figure 1.5: Total and per capita healthcare spending by country (2009) ..14

Figure 1.6: Share of population covered by private health insurance by country .17

Figure 1.7: Healthcare expenditure per capita by country (US$, World 2007) 19

Figure 1.8: Healthcare spending by type of service and product (US 2009) 20

Figure 2.1: Overview of telecom eHealth and mHealth services.24

Figure 2.2: Leading smartphone vendors and operating systems.32

Figure 2.3: Examples of mobile application stores (December 2010) .34

Figure 2.4: Examples of HealthVault-certified devices .37

Figure 2.5: Examples of Continua-certified devices ..38

Figure 2.6: Selected members of the Continua Health Alliance, by industry 39

Figure 3.1: Examples of methods for uploading health monitoring data 45

Figure 3.2: Overview of remote ECG monitoring.51

Figure 3.3: Heart sensor and monitor from CardioNet .52

Figure 3.4: Blood pressure monitor from Omron Healthcare 53

Figure 3.5: Glucose meters from LifeScan and Roche.56

Figure 3.6: Cost versus time diagram for wireless technology integration 64

Figure 4.1: Major suppliers of physiological monitoring solutions (2009) .68

Figure 4.2: Brands used by major diabetes monitoring companies .89

Figure 5.1: Examples of integrated monitoring solution providers 95

Figure 5.2: The Intel Health Guide..96

Figure 5.3: The Honeywell Genesis DM telehealth monitor with peripherals 97

Figure 6.1: Home medical monitoring market value by segment (World 2009–2015)..109

Figure 6.2: Home medical monitoring connections (World 2009–2015)..116

To order this report:

e-Healthcare Industry: mHealth and Home Monitoring – 3rd Edition

e-Healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker